Dr. Sameer Jejurikar is a board-certified plastic surgeon and voted one of the most compassionate doctors in the United States according to the patients themselves. In 2012 the Dallas, Texas-based Jejurikar was presented with the Compassionate Doctor Certification. This award was based on 100 million patients who reviewed their physicians online through sites like Patients’ Choice and Vitals. This honor was only bestowed upon about 3% of the active physicians in the United States. Dr. Sameer Jejurikar, known as Dr. Sam to his patients, received near perfect scores on patient ratings.
A member of the Alpha Omega Alpha Honor Society upon receipt of his MD through the University of Michigan Medical School, he also earned his bachelors at the University of Michigan as well as completing his residency through their medical center. Jejurikar is a member of both the American Society for Aesthetic Plastic Surgery and the American Society of Plastic Surgeons. In 2006, he completed an aesthetic surgery fellowship at the Manhattan Eye, Ear, and Throat Hospital.
The world-renowned Dallas Plastic Surgery Institute is where Dr. Sameer has worked out of for almost 9 years, since 2009. Prior to this, he was a senior staff surgeon for Scott and White. He specializes in both reconstructive and aesthetic surgery which makes him a top choice for complicated cases of surgery. His compassion for his patients makes the process easier as he cares for them mentally as well as physically. This stress-reducing method can help make the healing process smoother and make the actual surgery less traumatic. He specializes in liposuction, tummy tucks, breast augmentations and more. He strives to help patients achieve their vision in the safest way he can.
New diseases are emerging every day. The drugs which were being used a decade ago are not as effective as they used to be back then. This scenario has given doctors a hard time as they try to come up with new ways to treat new diseases. Amicus Therapeutics is a biotechnology company that focuses on finding ways to fight rare and orphan illnesses through the use of therapies. The global company uses unique technology and medicine as well to help people suffering from devastating diseases such as Lysosomal Storage Disorders, skin disorders, and Pompe disease.
Amicus Therapeutics was founded in 2002 and has around five hundred employees. It has its headquarters in Cranbury, New Jersey. The company cares for the many patients suffering from rare diseases which have troubled doctors from other medical institutions and ensures that they get the best care possible. The specialists in the company come up with clinical programs and carry out inventive science to create a platform where these people with the rare disorders can seek medical attention and be treated.
The goal of Amicus Therapeutics is to make a difference that is meaningful in the lives of all those patients with these critical conditions (https://www.dialdish.com/amicus-therapeutics-fabry-disease/). Many patients who have received help from the company and recovered fully from the special conditions claim that they had suffered for a long time before hearing about Amicus Therapeutics. Many reports that they were almost giving up after searching for solutions from many hospitals and clinics without success. That is how important the company is; for many people, it is usually the last hope.
Before 2008, Amicus Therapeutics had only one site, which was located in New Jersey (AliveNewspaper). This was before the company opened another one in San Diego. The company has received financial support from many sources due to its good work including grants from the Michael J. Fox Foundation and Alzheimer’s Drug Discovery Foundation.
Today, Amicus Therapeutics continues to look for better ways to help patients under the leadership of John F. Crowley who is the CEO and chairman of the company. Patients with these rare disorders will continue to get the help they need from the medical specialists for many years to come.